N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis

BACKGROUND: Progressive multiple sclerosis (PMS) is an uncommon and severe subtype of MS that worsens gradually and leads to irreversible disabilities in young adults. Currently, there are no applicable or reliable biomarkers to distinguish PMS from relapsing–remitting multiple sclerosis (RRMS). Pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Fei, Wang, Tianzhu, Wu, Xiaoxin, Liang, Jie, Li, Jiaoxing, Sheng, Wenli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296732/
https://www.ncbi.nlm.nih.gov/pubmed/34294105
http://dx.doi.org/10.1186/s12967-021-02981-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296732/
https://www.ncbi.nlm.nih.gov/pubmed/34294105
http://dx.doi.org/10.1186/s12967-021-02981-5

Ejemplares similares